Education
About Us
Working with TipRanks
Follow Us
IVSS - ETF AI Analysis
Top Page
Applied Finance IVS US SMID ETF (IVSS)
Rating:69Neutral
Price Target:―
Positive Factors
Diversified Sector Exposure
The ETF invests across a wide range of sectors, reducing the risk of being overly reliant on one industry.
Strong U.S. Focus
With nearly all its exposure in U.S. companies, the ETF benefits from stability in the U.S. market.
Balanced Top Holdings
The top holdings are relatively evenly distributed, avoiding over-reliance on a single stock.
Negative Factors
High Expense Ratio
The ETF charges a higher expense ratio compared to many similar funds, which can eat into returns over time.
Small Asset Base
The fund has a relatively low level of assets under management, which could lead to lower liquidity and higher trading costs.
Limited Geographic Diversification
The ETF is heavily concentrated in the U.S., offering little exposure to international markets.
IVSS vs. SPDR S&P 500 ETF (SPY)
AUM13.06M
RegionNorth America
Expense Ratio0.59%
Beta0.84
IssuerApplied Finance
Inception DateDec 03, 2025
Dividend Yield0.07%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume5,992
30 Day Avg. Volume11,912
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
31.02Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering357
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
IVSS Summary
The Applied Finance IVS US SMID ETF (IVSS) is an actively managed fund that focuses on small- and mid-sized companies in the United States. It uses a unique Intrinsic Value Stewardship model to identify businesses with strong growth potential. The ETF includes companies across various industries, such as technology and healthcare, with holdings like The Ensign Group and InterDigital. Investors might consider this ETF for diversification and exposure to smaller firms that are often overlooked but can offer high growth opportunities. However, new investors should be aware that smaller companies can be more volatile and sensitive to market changes.
How much will it cost me?The Applied Finance IVS US SMID ETF (IVSS) has an expense ratio of 0.59%, meaning you’ll pay $5.90 per year for every $1,000 invested. This is higher than average because it’s an actively managed fund, which typically involves more research and decision-making compared to passively managed funds that track an index.
What would affect this ETF?The Applied Finance IVS US SMID ETF (IVSS) could benefit from strong growth in small- and mid-cap U.S. companies, particularly in sectors like Technology and Consumer Cyclical, which are well-represented in its portfolio. However, it may face challenges from rising interest rates or economic slowdowns, which can negatively impact smaller companies and growth-oriented sectors. Additionally, its focus on the U.S. market makes it sensitive to domestic economic conditions and regulatory changes.
IVSS Top 10 Holdings
IVSS leans into U.S. small- and mid-caps, with a noticeable tilt toward tech and health care names that are doing much of the heavy lifting. Solar-tracking player Nextracker is rising and helps power returns, while Fabrinet and Atmus Filtration add to the upside with steady-to-strong momentum. On the health care side, Maximus and Option Care Health are quietly pulling their weight. The main drag comes from The Ensign Group, which has been losing a bit of steam lately. Overall, the fund is U.S.-only and moderately concentrated in innovative, economically sensitive sectors.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Nextpower Inc | 2.75% | $358.91K | $18.09B | 170.10% | 78 Outperform | |
| Ryman | 2.08% | $271.69K | $6.17B | -5.21% | 66 Neutral | |
| The Ensign Group | 1.83% | $238.55K | $11.58B | 54.39% | 78 Outperform | |
| InterDigital | 1.81% | $236.13K | $9.67B | 81.39% | 76 Outperform | |
| Option Care Health | 1.53% | $199.78K | $5.27B | 5.13% | 73 Outperform | |
| Southwest Gas | 1.36% | $177.92K | $5.98B | 7.37% | 74 Outperform | |
| Atmus Filtration Technologies, Inc. | 1.36% | $176.99K | $5.06B | 50.18% | 78 Outperform | |
| Fabrinet | 1.32% | $171.65K | $17.98B | 142.35% | 78 Outperform | |
| Maximus | 1.29% | $168.31K | $4.09B | 10.79% | 74 Outperform | |
| PJT Partners | 1.25% | $163.32K | $7.88B | -5.87% | 71 Outperform |
IVSS Technical Analysis
Positive
―
Price Trends
Market Momentum
0.35
Negative
65.78
Neutral
77.47
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For IVSS, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 26.85, equal to the 50-day MA of ―, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of 0.35 indicates Negative momentum. The RSI at 65.78 is Neutral, neither overbought nor oversold. The STOCH value of 77.47 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IVSS.
IVSS Peer Comparison
Comparison Results
Performance Comparison
IVSS
Applied Finance IVS US SMID ETF
27.49
2.28
9.04%
OASC
OneAscent Small Cap Core ETF
―
―
―
SMOX
Horizon Small/Mid Cap Core Equity ETF
―
―
―
ASCE
Allspring SMID Core ETF
―
―
―
HSMV
First Trust Horizon Managed Volatility Small/Mid ETF
―
―
―
MYLD
Cambria Micro and SmallCap Shareholder Yield ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents